Nutriset SAS

Malaunay, France

Nutriset SAS

Malaunay, France
SEARCH FILTERS
Time filter
Source Type

A recent intelligence study by Transparency Market Research (TMR) has detected that the global ready-to-use therapeutic food (RUTF) and ready-to-use supplementary food (RUSF) market is divided among several multinational companies, who hold nearly the half of the shares, and a large number of regional players that are catering to the rest of the demand. The primary target of these market leaders is Europe, owing to the increasing procurement of ready-to-eat food in this region. Most of the regional and local players are having a foray in the regions of Asia Pacific and Africa, targeting humanitarian organizations such as UNICEF, WFP, and other well-known NGOs. The report identifies Nutriset SAS, Mana Nutritive Aid Products, GC Rieber Compact AS, and Valid Nutrition as some of the key companies in the global RUTF and RUSF market, whereas other notable vendors are Edesia USA, Diva Nutritional Products, Hilina, Insta Products, InnoFaso, NutriVita Foods, Tabatchnik Fine Foods, Kaira District Cooperative, Power Foods Tanzania, 13.3.15. Meds & Food for Kids, Nuflower Foods and Nutrition Pvt., and Samil Industrial Co. As per the estimations of the TMR report, the demand in the global ready-to-use therapeutic food and supplementary food market will increment at a healthy CAGR of 8.6% during the forecast period of 2017 to 2025, reaching a valuation of US$829.3 mn by the end of 2025, remarkably up from its evaluated worth of US$429.9 mn in 2017. Based on product, the report segments the global ready-to-use therapeutic food and supplementary food market into RUTF and RUSF. While RUTF segment is sub-segmented into solid form such as power blends, biscuit, or bar, paste, and drinkable, RUSF segment is divided into solid and paste. In 2017, RUTF sub-segments collectively accounted for 70.1% of the demand, and are expected to further gain into the share of RUSF segment over the course of the forecast period. As far as end-users are concerned, the report classifies them into UNICEF, WFP, and NGOs, and rates UNICEF as most profitable end-user, accounting for more than two third of market and expected to add to the demand share through the duration of the forecast period. In 2017, Europe accounted for 54.3% of the demand in the global ready-to-eat therapeutic food and supplementary food market, a long way ahead of the second most lucrative region of the Middle East and Africa. In the near future, although Europe is expected to slightly lose the demand share, it still will be the most profitable region, maintain more than half of the overall demand for RUTF and RUSF. A number of factors are driving the demand in the global ready-to-eat therapeutic food and supplementary food market, such as increased government and NGO concerns regarding malnutrition treatment as a result of escalating population across the world, rising demand for drinkable RUTF products, and rising global emergencies and disasters. The report observes that various government bodies and NGOs such as UNICEF and Save the Children are reporting increasing malnutrition and child mortality rates. These organizations along with a number of government funded initiatives are focusing on allocating funds for purchase and distribution of RUTF and RUSF in under-privileged countries in Africa. On the other hand, increasing consumer and local government shift towards local ingredients, inconsistency in RUTF milk product, risk of contamination, and the common belief that RUTF and RUSF may undermine breast feeding are some of the key challenges faced by the vendors of this market. Nevertheless, the companies operating in this market are expected to gain new opportunities from encouragement of UNICEF to domestically produce RUTF and escalated research on raw materials as well as the development of new, drinkable, powdered, and bar form of RUTF. The information presented in this review is based on a Transparency Market Research report, titled, "Ready-to-use Therapeutic Food and Supplementary Food (RUTF & RUSF) Market (Product - RUTF (Solid (Powder or Blends and Biscuit or Bar), Paste, and Drinkable) and RUSF (Solid and Paste); End Users - UNICEF, WFP, and NGOs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025." The report segments the global RUTF and RUSF market as: Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


A recent intelligence study by Transparency Market Research (TMR) has detected that the global ready-to-use therapeutic food (RUTF) and ready-to-use supplementary food (RUSF) market is divided among several multinational companies, who hold nearly the half of the shares, and a large number of regional players that are catering to the rest of the demand. The primary target of these market leaders is Europe, owing to the increasing procurement of ready-to-eat food in this region. Most of the regional and local players are having a foray in the regions of Asia Pacific and Africa, targeting humanitarian organizations such as UNICEF, WFP, and other well-known NGOs. The report identifies Nutriset SAS, Mana Nutritive Aid Products, GC Rieber Compact AS, and Valid Nutrition as some of the key companies in the global RUTF and RUSF market, whereas other notable vendors are Edesia USA, Diva Nutritional Products, Hilina, Insta Products, InnoFaso, NutriVita Foods, Tabatchnik Fine Foods, Kaira District Cooperative, Power Foods Tanzania, 13.3.15. Meds & Food for Kids, Nuflower Foods and Nutrition Pvt., and Samil Industrial Co. As per the estimations of the TMR report, the demand in the global ready-to-use therapeutic food and supplementary food market will increment at a healthy CAGR of 8.6% during the forecast period of 2017 to 2025, reaching a valuation of US$829.3 mn by the end of 2025, remarkably up from its evaluated worth of US$429.9 mn in 2017. Based on product, the report segments the global ready-to-use therapeutic food and supplementary food market into RUTF and RUSF. While RUTF segment is sub-segmented into solid form such as power blends, biscuit, or bar, paste, and drinkable, RUSF segment is divided into solid and paste. In 2017, RUTF sub-segments collectively accounted for 70.1% of the demand, and are expected to further gain into the share of RUSF segment over the course of the forecast period. As far as end-users are concerned, the report classifies them into UNICEF, WFP, and NGOs, and rates UNICEF as most profitable end-user, accounting for more than two third of market and expected to add to the demand share through the duration of the forecast period. In 2017, Europe accounted for 54.3% of the demand in the global ready-to-eat therapeutic food and supplementary food market, a long way ahead of the second most lucrative region of the Middle East and Africa. In the near future, although Europe is expected to slightly lose the demand share, it still will be the most profitable region, maintain more than half of the overall demand for RUTF and RUSF. A number of factors are driving the demand in the global ready-to-eat therapeutic food and supplementary food market, such as increased government and NGO concerns regarding malnutrition treatment as a result of escalating population across the world, rising demand for drinkable RUTF products, and rising global emergencies and disasters. The report observes that various government bodies and NGOs such as UNICEF and Save the Children are reporting increasing malnutrition and child mortality rates. These organizations along with a number of government funded initiatives are focusing on allocating funds for purchase and distribution of RUTF and RUSF in under-privileged countries in Africa. On the other hand, increasing consumer and local government shift towards local ingredients, inconsistency in RUTF milk product, risk of contamination, and the common belief that RUTF and RUSF may undermine breast feeding are some of the key challenges faced by the vendors of this market. Nevertheless, the companies operating in this market are expected to gain new opportunities from encouragement of UNICEF to domestically produce RUTF and escalated research on raw materials as well as the development of new, drinkable, powdered, and bar form of RUTF. The information presented in this review is based on a Transparency Market Research report, titled, "Ready-to-use Therapeutic Food and Supplementary Food (RUTF & RUSF) Market (Product - RUTF (Solid (Powder or Blends and Biscuit or Bar), Paste, and Drinkable) and RUSF (Solid and Paste); End Users - UNICEF, WFP, and NGOs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025." The report segments the global RUTF and RUSF market as: Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Adu-Afarwuah S.,University of Ghana | Lartey A.,University of Ghana | Zeilani M.,Nutriset SAS | Dewey K.G.,University of California at Davis
Maternal and Child Nutrition | Year: 2011

Inadequate micronutrient intake during pregnancy, lactation and infancy is a major problem in many developing countries. Lipid-based nutrient supplements (LNS) can improve micronutrient status, growth and development of infants, and also have potential to improve nutritional status of pregnant and lactating women. The objective of the study was to test the acceptability of LNS designed for infants (LNS-20gM) and pregnant or lactating women (LNS-P&L). Participants were infants (n=22, mean age=8 months) and pregnant or lactating women (n=24) attending routine services at a hospital in Ghana. Infants consumed 45g of a test meal consisting of one part LNS-20gM and three parts fermented maize porridge, while women consumed 50g of a similar test meal containing LNS-P&L instead. Participants also used their respective LNS at home for 14 days. Primary outcome was the proportion of the test meal consumed. On average, infants consumed 76.2% of the test meal [95% (confidence interval) CI: 65.7, 86.7], while women consumed 87.1% (95% CI: 82.6, 91.6). During the 14-day period, median daily consumption of LNS-20gM was 19.3g, very close to the recommended 20gd -1, while that of LNS-P&L was one sachet, as recommended. We conclude that LNS-20gM and LNS-P&L were well accepted. © 2010 Blackwell Publishing Ltd.


News Article | November 30, 2016
Site: www.newsmaker.com.au

the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 25, 2016
Site: www.newsmaker.com.au

The global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 18, 2016
Site: www.newsmaker.com.au

Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. According to Persistence Market Research report, titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 22, 2016
Site: www.newsmaker.com.au

Universally, malnutrition is believed to contribute to nearly half of all child deaths. Malnutrition can be chronic, resulting to stunting. According to WHO Child Growth Standards that chart the progress of a reference population, a stunted child endures a short height with respect to age. An acute malnutrition causes wasting and a child who is wasted has a low weight for his height. According to Persistence Market Research report, titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, the global ready-to-use therapeutic food market in 2015 was valued at US$ 249.2 million, and is anticipated estimated to account for value worth US$ 276 million by the end of 2016, exhibiting a Y-o-Y growth rate of 10.7% while in terms of value, it is anticipated to grow at a healthy CAGR of 10.6% in the forecast period from 2016 to 2024. Malnutrition is caused by not having enough of essential food and necessary nutrition. Among children, recurrent infections is the prime cause of malnutrition in many tropical countries. Mostly, inadequate nutrition restricts recovery from infection, thus setting up a vicious illness and malnutrition cycle. One way to break this vicious cycle is by providing ill children with nutritional supplements, viz. Ready-To-Use Drinkable Therapeutic Food (RUTF). They have proved to be highly active in promoting rapid weight gain in children suffering from severe acute malnutrition. Factors that are driving the market growth of ready-to-use therapeutic food include growing demand of drinkable ready-to-use therapeutic foods and increasing global disasters and emergencies. Due to easy storage and distribution, the demand for semi-solid paste therapeutic foods is fueling the revenue growth of the market. However, factors that are hampering the market growth of ready-to-use therapeutic food such as customers shifting towards foods having local ingredients and risk of contamination due to inconsistencies in RUTF milk products. The global market of ready-to-use therapeutic food is categorized into product type and regions. Based on product type, the global market of ready-to-use therapeutic food is categorized as solid (biscuits/bar and powder/blends), drinkable therapeutic food and semi-solid paste. Among these, the section of powder/blends in the global market of ready-to-use therapeutic food will account for US$ 1.5 million in the forecast period from 2016 to 2024, exhibiting a CAGR of 11.2%. Meanwhile, the segment of biscuits/bar will register a CAGR of 8.7%, accounting for US$ 7.8 million during the forecast period. The segment of semi-solid paste is anticipated to remain dominant in the global market of ready-to-use therapeutic food. Regionally, the ready-to-use therapeutic food market is categorized as North America, the MEA, Europe, and APAC. The MEA market will probably account for relatively higher revenue in the global market of ready-to-use therapeutic food market while the North America market is expected to be reach US$ 35.7 million by the end of 2016 and it is anticipated to exhibit a healthy CAGR of 10.3%, valued at US$ 78.2 million between 2016 and 2024. The Europe region is estimated to witness maximum revenue share and higher production capacity in the global market of ready-to-use therapeutic food market during the forecast period. The APAC market is estimated to reach US$ 27.2 million during the forecast period. Additionally, in the APAC region, availability of cost-effective raw materials will boost the production of ready-to-use therapeutic foods and consequently fuel the market during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The key market players operating in the market for ready-to-use therapeutic food include Compact AS, Tabatchnik Fine Foods, Edesia USA, NutriVita Foods, Diva Nutritional Products, Nutriset SAS, InnoFaso , Mana Nutritive Aid Products, Hilina and Insta Products. Over the forecast period, the segment of drinkable therapeutic food is projected to gain significant market share of the global market for ready-to-use therapeutic food.


News Article | November 12, 2016
Site: www.newsmaker.com.au

In a new report titled “Ready-to-use Therapeutic Food Market: Global Industry Analysis and Forecast, 2016–2024”, Persistence Market Research delivers key insights on the global ready-to-use therapeutic food market and analyzes the key factors and trends impacting market performance over an eight-year forecast period (2016 – 2024). In 2015, the global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market


News Article | December 6, 2016
Site: www.newsmaker.com.au

Persistence Market Research delivers key insights on the global ready-to-use therapeutic food market and analyzes the key factors and trends impacting market performance over an eight-year forecast period (2016 – 2024). In 2015, the global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market.


News Article | November 28, 2016
Site: www.newsmaker.com.au

Global ready-to-use therapeutic food market was valued at US$ 249.2 Mn, and this is estimated to increase to US$ 276.0 Mn by 2016 end, reflecting a Y-o-Y growth rate of 10.7%. In terms of value, the global ready-to-use therapeutic food market is expected to register a CAGR of 10.6% during the forecast period. Increasing government as well as NGO focus on the treatment of malnutrition is expected to drive revenue growth of the global ready-to-use therapeutic food market over the forecast period. Also, an increasing demand for drinkable ready-to-use therapeutic foods and rising global emergencies and disasters is expected to further fuel market growth. Demand for semi-solid paste therapeutic food products as a result of easy storage and distribution is fueling the demand for ready-to-use therapeutic food products to manage people suffering from severe acute malnutrition. Demand for ready-to-use drinkable therapeutic food is increasing with the government focusing on increasing the procurement of drinkable ready-to-use foods for small children. Rise in regional government bodies and global manufacturers planning to establish local manufacturing facilities is another major driving factor fueling the growth of the global ready-to-use therapeutic food market. However, increasing consumer/local government shift towards local ingredients and inconsistencies in ready-to-use therapeutic food milk products thereby creating a risk of contamination are factors likely to restrict market growth during the forecast period. The global ready-to-use therapeutic food market offers great opportunities for market players with UNICEF encouraging the domestic production of ready-to-use therapeutic foods. The global ready-to-use therapeutic food market is segmented on the basis of Product Type into Solid (Powder/Blends, Biscuits/Bar), Semi-solid Paste, and Drinkable Therapeutic Food; and on the basis of Region into North America, Asia Pacific (APAC), Europe, and Middle East & Africa (MEA). The Powder/Blends solid segment is estimated to create incremental $ opportunity of US$ 1.5 Mn between 2016 and 2024, registering a CAGR of 11.2% during the forecast period. The Biscuits/Bar solid segment is estimated to create incremental $ opportunity of US$ 7.8 Mn between 2016 and 2024, witnessing a CAGR of 8.7% during the forecast period. The Semi-solid Paste segment is expected to retain its dominance in the global ready-to-use therapeutic food market throughout the forecast period, with 90.7% value share by 2024. Among regions, Europe is estimated to account for a maximum revenue share of 62.0% of the global ready-to-use therapeutic food market by the end of 2016. The MEA market is expected to account for 19.1% market share of the global ready-to-use therapeutic food market by the end of 2016. The Europe ready-to-use therapeutic food market is estimated to be valued at US$ 171.0 Mn by 2016 end and is expected to increase to US$ 355.7 Mn by 2024 end, registering a CAGR of 9.6% during the forecast period. For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/ready-to-use-therapeutic-food-market/toc This report covers detailed profiles of key players operating in the global ready-to-use therapeutic food market – Insta Products (EPZ) Ltd., MANA, Nutrivita Foods Pvt Ltd., Power Foods Industries Ltd., Tabatchnick Fine Foods, HILINA Enriched Food Processing Center P.L.C., GC Rieber Compact AS, Diva Nutritional Products, Edesia, Inc., Nutriset, and InnoFasoSA. Ease of product availability, rising malnutrition population in developing nations, and an easy storage and distribution network are factors encouraging new players to venture into the global ready-to-use therapeutic food market. Established players in the global ready-to-use therapeutic food market are expanding production facilities and are focusing on product innovations, which is creating robust competition in the global ready-to-use therapeutic food market.

Loading Nutriset SAS collaborators
Loading Nutriset SAS collaborators